C82.0A
Follicular lymphoma grade I, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, which is part of the body's immune defense. When diagnosed as grade I, it indicates a slow-growing form of this lymphoma. The designation 'in remission' suggests that previous treatments have successfully reduced or eliminated signs of the disease, and current evaluations do not show active cancer. Recognizing this diagnosis helps patients understand their condition and the importance of ongoing monitoring and care.
Causes & Symptoms
Clinical Causes: The exact cause of follicular lymphoma, including grade I, remains largely unknown. However, several factors may contribute to its development: - Genetic mutations: Changes in specific genes can lead to abnormal growth of lymphocytes. - Age: The risk increases with age, typically affecting adults over 60. - Immune system conditions: Certain immune deficiencies or autoimmune diseases may be associated. - Past exposure to radiation or certain chemicals: Although evidence is limited, some environmental exposures could play a role. - Family history: A family history of lymphoma or other blood cancers may increase risk.
Key Symptoms: Follicular lymphoma can grow without noticeable symptoms, especially in its early stages. When symptoms do occur, they might include: - Painless swelling of lymph nodes in the neck, armpits, or groin - Fatigue or weakness - Unexplained weight loss - Fever or night sweats - Persistent infections - Loss of appetite Since these symptoms can overlap with other illnesses, regular medical evaluations are essential for proper assessment.
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma involves several steps: - Physical examination: Checking for enlarged lymph nodes or other signs. - Biopsy: Removing a sample of lymph node tissue for microscopic analysis to confirm lymphoma type and grade. - Imaging tests: CT scans, PET scans, or MRI to determine the extent of disease spread. - Blood tests: To evaluate overall health and organ function. - Bone marrow biopsy: To check for lymphoma involvement in the marrow. The diagnosis of 'in remission' is based on recent evaluations showing no apparent signs of active disease following treatment.
Treatment Protocols: While follicular lymphoma is considered incurable, many patients respond well to treatment and can enjoy extended periods of remission. Management options include: - Observation: For certain low-grade cases in remission, careful monitoring without immediate treatment. - Immunotherapy: Using medications that help the immune system target cancer cells. - Chemotherapy: To eliminate lymphoma cells when necessary. - Targeted therapy: Drugs that specifically target cancer cell mechanisms. - Radiation therapy: In localized cases or for symptom relief. - Maintenance therapy: To prevent relapse during remission. Ongoing follow-up care and regular assessments are crucial to detect any recurrence early.
Clinical Advice & FAQs
Billing Guidance
Is C82.0A a billable ICD-10 code?
Yes, C82.0A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.0A?
Clinical documentation must specify the nature of Follicular lymphoma grade I, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
